| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |